Our assessment
FORM by GBY sells compounded semaglutide and tirzepatide as injections, oral tablets and three-component stacks, and it puts the first-month rate and the ongoing rate in the same sentence on both injectable product pages. That is a good habit. The problem is that its own weight-loss overview quotes different figures for the same products, including two different monthly prices for one microdose pathway. Which number applies depends on which page you land on.
The intro rate and the standing rate, together
Both single-product injectable pages state the first-month price and the price thereafter in one sentence. That is the disclosure most sellers relegate to a footnote or leave out entirely, and it shows you the promotional shape of the offer without any work.
Budget from the standing rate. The first-month figure is an introductory offer with a stated length, and it ends.
The same product at two prices
The microdose tirzepatide product page and the weight-loss overview state different monthly figures for the same pathway. The overview also prices the three-component semaglutide and tirzepatide stacks well above the single-product pages, with different first-month rates again.
Some of that is explicable — a three-component formula is a different product from a single compounded injection — but the microdose discrepancy is not, and nothing on the site reconciles any of it. Note which page a figure came from before you treat it as the price.
Two routes, and the oral one costs more
Orally dissolving tablets are priced for both molecules at a stated monthly rate, above the corresponding injection in each case. Publishing an oral route with a real price rather than an inquiry form is uncommon and useful.
The three-component stacks bundle a GLP-1 with two other ingredients under one figure. A blend price is not the price of the molecule inside it, so don't set a stack figure against a single-drug figure and call it a comparison.
Brand names appear as memberships
The catalog lists brand-name products as membership items, so a brand route exists, but no page prices one or says what such a membership costs.
No compounding pharmacy is named beyond US-licensed or state-licensed. No list of states served appears anywhere, and no individual prescribing clinician or medical director is identified. The site does state on every page that compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness or quality.
FORM by GBY's published pricing
Prices re-verified September 2026
| Medication | Price |
|---|---|
| MedicationSemaglutide (compounded) — personalised dose, once weekly | Price$159/mothe ongoing monthly rate, with a lower first-month price — a separate overview page lists different figures for a 3-component semaglutide stack |
| MedicationTirzepatide (compounded) — personalised dose, once weekly | Price$219/mothe ongoing monthly rate, with a lower first-month price — a separate overview page lists different figures for a 3-component tirzepatide stack |
| MedicationTirzepatide (compounded) — clinician-directed microdose | Price$199/moper month for the microdose option — a separate overview page prices the same option at $299/month, so the seller states two figures for it |
| MedicationSemaglutide (compounded-oral) — orally dissolving tablet | Price$215/moper month for the oral version, priced above the weekly injection |
| MedicationTirzepatide (compounded-oral) — orally dissolving tablet | Price$299/moper month for the oral version, priced above the weekly injection |
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
See FORM by GBY's current price →Who FORM by GBY suits
Good fit if
- Readers who want an oral and an injectable route from one brand, both priced openly.
- Patients who want the introductory rate and the rate that follows it stated in the same sentence.
- Anyone considering a lower-dose pathway, which is priced here as its own product.
- Readers who want the constituents of a stack named rather than hidden behind a product name.
Look elsewhere if
- Anyone who cannot check which page a quoted figure came from, because this site prices the same pathway two ways.
- Readers comparing ongoing costs on headline figures, since every advertised entry price here is a first-month rate.
- Patients who need the compounding pharmacy named or the state footprint published.
- Anyone who wants a priced brand-name route rather than an unpriced membership listing.
What stands out about FORM by GBY
Strengths
- Prints the introductory rate and the rate that follows it in the same sentence on both injectable product pages, rather than footnoting the second one
- Offers an oral route for each drug at a stated monthly price, so the needle-free option is a priced choice and not an inquiry
- Names the constituent compounds in every stack, so a reader can see that a bundle contains more than the GLP-1 they came for
- States on every page that compounded medications are not FDA-approved and that the FDA does not review them for safety, effectiveness or quality
- No FDA warning letter identified for this company in our September 2026 search
Trade-offs
- Product pages and the weight-loss overview show different prices for the same pathways. Request a current written quote before choosing a plan.
- Every advertised entry price is a first-month rate, so the headline is never what an ongoing month costs
- The three-component FORM 3 formula bundles the GLP-1 with two other ingredients, so its figure is a blend price and is not recorded here as a semaglutide or tirzepatide price
- The compounding pharmacy is described as US-licensed or state-licensed and never named
- No list of states served, and no individual prescribing clinician or medical director, appears anywhere we read
How this review was verified
- The semaglutide, tirzepatide, microdose tirzepatide and both oral tablet product pages, plus the weight-loss overview, were read.
- Each single-product page states the first-month rate and the ongoing rate in one sentence.
- The microdose tirzepatide product page and the weight-loss overview give two different monthly figures for the same pathway. Nothing on the site reconciles them.
- The three-component stack figures cover three ingredients together, so none of them is a semaglutide or tirzepatide price.
- Brand-name products are listed as membership items with no price and no stated membership cost.
Where FORM by GBY ranks
FORM by GBY qualifies for 4 of the 6 boards on this site. A board only ranks the providers that meet its own condition, so a missing board means FORM by GBY does not publish what that board sorts on.
- Semaglutide — #255 of 334
- Tirzepatide — #232 of 319
- Cheapest Overall — #291 of 396
- Oral — #84 of 108
Compare FORM by GBY directly
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
| Provider | Score | From/mo | Full review | Action |
|---|---|---|---|---|
| Belle Health | 10.0/10 | From/mo$109Advertised monthly equivalent for a twelve-month supply; not a verified monthly installment. Six-month rate $119, two-month rate $135, one-month rate $199. Confirm the upfront payment and refill schedule. | Full reviewRead the Belle Health review | Visit |
| Midi Health | 10.0/10 | From/mo$164for a 4-week supply, the lowest of four published dose tiers, including shipping | Full reviewRead the Midi Health review | Visit |
| altRx | 8.6/10 | From/mo$89/moadvertised monthly starting price for a multi-dose vial; confirm plan length and checkout total | Full reviewRead the altRx review | Visit |
Frequently asked questions
Which price is right, the product page or the overview?
The site doesn't say, and they differ. Its microdose tirzepatide page and its weight-loss overview state two different monthly figures for the same pathway, and the overview prices the three-component stacks well above the single-product pages. Note which page your figure came from before treating it as settled.
Is the advertised price the ongoing price?
No. Every advertised entry price is a first-month rate, with the standing rate printed in the same sentence. Budget from the standing rate.
Is there an oral option?
Yes, orally dissolving tablets for both molecules at a stated monthly rate. Both cost more than the corresponding injection, which is the usual direction but is worth knowing before you assume a tablet is the cheaper route.
What is in the three-component formula?
A GLP-1 plus two other ingredients, named on the page. Because the figure covers all three, it is not the price of the GLP-1 on its own and should not be compared against one.
Is a brand-name option available?
The catalog lists brand-name products as membership items, so a route appears to exist, but no page prices one or says what the membership costs. Treat it as an open question.
Ready to compare directly?
FORM by GBY scores 2.9/10 on this site's rubric. Review the published prices and their conditions above, then confirm your total with the provider. Visiting its site does not commit you to treatment.
Compare GLP may earn a commission when a reader signs up with a provider through a link on this site. 28 of the 420 providers reviewed here are paid partners today; the other 392 are not. See how this works.
Visit FORM by GBY →